Letao Bo
Impact in
- Microbiology top 1%
- Antimicrobial Peptides and Activities
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 5
-
- Cancer therapeutics and mechanisms 3
- RNA Interference and Gene Delivery 1
- Co-authors
- Zhe‐Sheng Chen (14 shared papers)Leming Sun (1 shared paper)Jiaye Wang (1 shared paper)Ruichen Wang (1 shared paper)Bowen Zhang (1 shared paper)Hui Yang (1 shared paper)Weiguo Feng (1 shared paper)Harsh Patel (5 shared papers)
- Journals
- Drug Resistance Updates (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Oncology (2 papers)Drugs of today (1 paper)Cancers (1 paper)
- Partner nations
- United StatesChinaIran
In The Last Decade
Letao Bo
14 papers receiving 612 citations
Letao Bo's Hit Papers
Peers
Comparison fields: 5 of 89
- Microbiology 269
- Molecular Medicine 62
- Applied Microbiology and Biotechnology 18
- Drug Discovery 1
- Molecular Biology 268
Countries citing papers authored by Letao Bo
This map shows the geographic impact of Letao Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Letao Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Letao Bo more than expected).
Fields of papers citing papers by Letao Bo
This network shows the impact of papers produced by Letao Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Letao Bo. The network helps show where Letao Bo may publish in the future.
Co-authors
The 25 scholars most cited alongside Letao Bo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial peptides for combating drug-resistant bacterial infections Hit paper breakdown → | 2023 | 446 |
| 2 | 2016 | 33 | |
| 3 | 2021 | 29 | |
| 4 | 2024 | 22 | |
| 5 | 2024 | 19 | |
| 6 | 2021 | 19 | |
| 7 | 2023 | 18 | |
| 8 | 2024 | 16 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2025 | 3 | |
| 13 | 2025 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Letao Bo
Letao Bo is a scholar working on Oncology, Molecular Biology, Infectious Diseases, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 624 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), HIV/AIDS drug development and treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Antibiotic Resistance in Bacteria (2 papers), Lung Cancer Treatments and Mutations (2 papers), Pneumonia and Respiratory Infections (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Microbiology (269 citations), Molecular Medicine (62 citations), Applied Microbiology and Biotechnology (18 citations), Drug Discovery (1 citation) and Molecular Biology (268 citations). Letao Bo has collaborated with scholars based in United States, China and Iran. Frequent co-authors include Zhe‐Sheng Chen, Leming Sun, Jiaye Wang, Ruichen Wang, Bowen Zhang, Hui Yang, Weiguo Feng, Harsh Patel, Zhuo‐Xun Wu and Yidong Li. Their work appears in journals such as Drug Resistance Updates, Frontiers in Pharmacology, Frontiers in Oncology, Drugs of today and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.